Cargando…

The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes

Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez Cruz, Pedro M., Palace, Jacqueline, Beeson, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032286/ https://www.ncbi.nlm.nih.gov/pubmed/29874875 http://dx.doi.org/10.3390/ijms19061677

Ejemplares similares

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
por: Liao, Xufeng, et al.
Publicado: (2023)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
por: Finlayson, Sarah, et al.
Publicado: (2016)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2019)

Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes
por: Webster, Richard G.
Publicado: (2018)

Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission
por: Cossins, Judith, et al.
Publicado: (2020)

Congenital myasthenic syndromes
por: Finsterer, Josef
Publicado: (2019)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
por: Cossins, Judith, et al.
Publicado: (2013)

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions
por: Nicole, Sophie, et al.
Publicado: (2017)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023)

The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies
por: Vanhaesebrouck, An E., et al.
Publicado: (2019)

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
por: McMacken, Grace M, et al.
Publicado: (2019)

β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure
por: Vanhaesebrouck, An E, et al.
Publicado: (2019)

The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2019)

Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome
por: Spendiff, Sally, et al.
Publicado: (2020)

Clinicopathological‐genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre
por: Huang, Kun, et al.
Publicado: (2022)

The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2020)

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes
por: McMacken, Grace, et al.
Publicado: (2018)

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era
por: Thompson, Rachel, et al.
Publicado: (2018)

Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain
por: Logan, Clare V., et al.
Publicado: (2015)

Autoregulation of Acetylcholine Release and Micro-Pharmacodynamic Mechanisms at Neuromuscular Junction: Selective Acetylcholinesterase Inhibitors for Therapy of Myasthenic Syndromes
por: Petrov, Konstantin A., et al.
Publicado: (2018)

Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome
por: Xi, Jianying, et al.
Publicado: (2017)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
por: Ginebaugh, Scott P., et al.
Publicado: (2022)

Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness
por: Evangelista, Teresinha, et al.
Publicado: (2015)

Congenital Myasthenic Syndrome in a Mixed Breed Dog
por: Blakey, Theresa J., et al.
Publicado: (2017)

Congenital myasthenic syndrome in China: genetic and myopathological characterization
por: Zhao, Yawen, et al.
Publicado: (2021)

NMJ-related diseases beyond the congenital myasthenic syndromes
por: Navarro-Martínez, Alejandra, et al.
Publicado: (2023)

Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models
por: Pugliese, Alessia, et al.
Publicado: (2023)

Congenital myasthenic syndromes: Natural history and long-term prognosis
por: Jagtap, Sujit Abajirao, et al.
Publicado: (2013)

Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1
por: Basiri, Keivan, et al.
Publicado: (2013)

Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia
por: Webster, Richard G, et al.
Publicado: (2020)

Classification of myasthenia gravis and congenital myasthenic syndromes in dogs and cats
por: Mignan, Thomas, et al.
Publicado: (2020)

Can Scoliosis Help the Early Diagnosis of Congenital Myasthenic Syndrome?
por: Kaya, Oğuz, et al.
Publicado: (2023)

Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by COLQ Mutations
por: Shao, Shuai, et al.
Publicado: (2023)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
por: Chang, Thashi, et al.
Publicado: (2016)

Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
por: Thompson, Rachel, et al.
Publicado: (2019)

The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease
por: Iyer, Shama R., et al.
Publicado: (2021)

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review
por: Ohno, Kinji, et al.
Publicado: (2023)

Bulbar dysfunction: An early presentation of congenital myasthenic syndrome in three infants
por: Khan, Arif, et al.
Publicado: (2011)

Congenital myasthenic syndromes: Clinical and molecular report on 7 Sicilian patients
por: Pavone, Piero, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b94qj0eiir046hsscqeehcdgla